Epidemiological data on the detection of immunoglobulins of class IgM, IgG to SARS-Cov-2 among population of Poltava region

dc.contributor.authorMarchenko, А. V.
dc.contributor.authorAnanieva, M. M.
dc.contributor.authorFaustova, M. O.
dc.contributor.authorLoban’, G. A.
dc.contributor.authorLytovchenko, I. Yu.
dc.contributor.authorNikolishyn, I. A.
dc.contributor.authorIlenko-Lobach, N. V.
dc.contributor.authorМарченко, Алла Володимирівна
dc.contributor.authorАнаньєва, Майя Миколаївна
dc.contributor.authorФаустова, Марія Олексіївна
dc.contributor.authorЛобань, Галина Андріївна
dc.contributor.authorЛітовченко, Ірина Юріївна
dc.contributor.authorНіколішин, Ігор Анатолійович
dc.contributor.authorІленко-Лобач, Наталія Володимирівна
dc.date.accessioned2021-06-08T12:11:12Z
dc.date.available2021-06-08T12:11:12Z
dc.date.issued2021
dc.description.abstractThe aim: Of this study was to analyze epidemiological data on the detection of immunoglobulins of class M and G (IgM, IgG) to SARS-CoV-2 among urban and rural population of Poltava region. Materials and methods: We have analyzed the research results of 2841 patients to determine IgM and IgG levels to SARS-CoV-2. The study included the results of patients in Poltava and nearby villages of Poltava region, obtained during July – December 2020. Results: Thus, 84% of patients applied for detection of IgM in the serum of patients with the pathogen COVID-2019. We have found only 135 positive results for the detection of IgM to SARS-CoV-2, which was 5.7% of the total number of people who underwent this study from July to December 2020. Moreover, women received a positive result more often than men. The IP samples for the detection of IgM to SARS-CoV-2 in the serum of patients averaged 2.5 ± 1.04. It was found that patients went to the laboratory to detect IgG to SARS-CoV-2 with the vast majority among them were residents of Poltava. However, in this case the share of positive results was 47.7%, among which the female population outnumbered the male. Conclusions: The frequency of detection of positive results on IgM to SARS-CoV-2 is about 6%. The share of positive results on IgG to SARS-CoV-2 was 47.7%, among them 76.2% were women. The frequency of detection of IgM and IgG to SARS-CoV-2 during October-December 2020 significantly exceeds the indices in July-September of the same year.uk_UA
dc.identifier.citationEpidemiological data on the detection of immunoglobulins of class IgM, IgG to SARS-Cov-2 among population of Poltava region / A. V. Marchenko, M. M. Ananieva, M. O. Faustova [et al.] // Wiadomosci Lekarskie. – 2021. – Vol. LXXIV, issue 5. – Р. 1134–1136.uk_UA
dc.identifier.doi10.36740/WLek202105116
dc.identifier.issn0043-5147
dc.identifier.urihttps://repository.pdmu.edu.ua/handle/123456789/16084
dc.language.isoenuk_UA
dc.publisher© Aluna Publishinguk_UA
dc.subjectIgGuk_UA
dc.subjectCOVID-2019uk_UA
dc.subjectfrequencyuk_UA
dc.subjectSARS-CoV-2uk_UA
dc.subjectIgMuk_UA
dc.titleEpidemiological data on the detection of immunoglobulins of class IgM, IgG to SARS-Cov-2 among population of Poltava regionuk_UA
dc.typeArticleuk_UA

Файли

Контейнер файлів
Зараз показуємо 1 - 1 з 1
Ескіз недоступний
Назва:
еpidemiological_data1.pdf
Розмір:
111.76 KB
Формат:
Adobe Portable Document Format
Ліцензійна угода
Зараз показуємо 1 - 1 з 1
Ескіз недоступний
Назва:
license.txt
Розмір:
4.3 KB
Формат:
Item-specific license agreed upon to submission
Опис: